HSBC Holdings’s Korro Bio KRRO Stock Holding History

HSBC Holdings’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-176	Closed	-$312K	–	2949
2020 Q4	$312K	Buy	+176	New	+$232K	﹤0.01%	2546

Other funds holding KRRO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HSBC Holdings's KRRO Position: Q1 2021 in Review

HSBC Holdings sold out of Korro Bio (KRRO) in Q1 2021, closing a stake of 176 shares — an estimated $312K sold.

HSBC Holdings first reported a position in KRRO in Q4 2020 and held it in 1 quarter. The position peaked at $312K in Q4 2020. 115 funds tracked by Wall St. Rank hold KRRO as of Q1 2021.

HSBC Holdings reported no remaining Korro Bio position as of Q1 2021 after selling out during the quarter.
HSBC Holdings sold 176 Korro Bio shares in Q1 2021, an estimated $312K.
HSBC Holdings first reported a position in Korro Bio in Q4 2020 and held it in 1 quarter.
HSBC Holdings's Korro Bio position peaked at $312K in Q4 2020.
115 funds tracked by Wall St. Rank held Korro Bio as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.